Cite
Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis.
MLA
Zhao, LiLi, et al. “Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating Circ_ITCH/MiR-421/CPEB3 Axis.” Digestive Diseases & Sciences, vol. 66, no. 12, Dec. 2021, pp. 4384–97. EBSCOhost, https://doi.org/10.1007/s10620-020-06787-1.
APA
Zhao, L., Ma, N., Liu, G., Mao, N., Chen, F., & Li, J. (2021). Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis. Digestive Diseases & Sciences, 66(12), 4384–4397. https://doi.org/10.1007/s10620-020-06787-1
Chicago
Zhao, LiLi, Ning Ma, Gaihong Liu, Ni Mao, Fei Chen, and Jiao Li. 2021. “Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating Circ_ITCH/MiR-421/CPEB3 Axis.” Digestive Diseases & Sciences 66 (12): 4384–97. doi:10.1007/s10620-020-06787-1.